Design and synthesis of boron-containing diphenylpyrimidines as potent BTK and JAK3 dual inhibitors
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 28 (2) , 115236
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moietiesBioorganic & Medicinal Chemistry Letters, 2011
- Synthesis and structure–activity relationships of novel benzoxaboroles as a new class of antimalarial agentsBioorganic & Medicinal Chemistry Letters, 2011
- Btk-dependent Rac activation and actin rearrangement following FcεRI aggregation promotes enhanced chemotactic responses of mast cellsJournal of Cell Science, 2010
- Gene expression profiles of infant acute lymphoblastic leukaemia and its prognostically distinct subsetsBritish Journal of Haematology, 2010
- Discovery of Novel Benzoxaborole-Based Potent Antitrypanosomal AgentsACS Medicinal Chemistry Letters, 2010
- Discovery and structure–activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitisBioorganic & Medicinal Chemistry Letters, 2009
- Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domainImmunological Reviews, 2009
- BLNK suppresses pre–B-cell leukemogenesis through inhibition of JAK3Blood, 2009
- Signalling of Bruton's Tyrosine Kinase, BtkScandinavian Journal of Immunology, 1999
- Role of Bruton's tyrosine kinase in immunodeficiencyCurrent Opinion in Immunology, 1994